ArticleJournal of the National Cancer Institute2026
Survivorship care and mortality in a contemporary and diverse cohort of childhood cancer survivors.
Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Supporting Survivor-Centered Care Through Digital Health Integration.Pediatric blood & cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundImplementing quality survivorship care for the growing population of cancer survivors is a national priority. The impact of comprehensive survivorship care on survival among childhood cancer survivors is unknown.
methodsThis retrospective analysis included patients eligible for receipt of a survivorship care plan in the institutional survivorship program at a comprehensive pediatric cancer center following initial diagnosis between 2002 and 2016. We followed survivors from eligibility to 10 years, death, or December 31, 2020, whichever occurred earliest. Cox proportional hazards models estimated the association of survivorship care plan receipt at an initial survivorship program visit with overall survival and event-free survival, adjusting for sociodemographic and cancer-related factors.
resultsAmong 3366 survivors, 1883 (55.9%) received a survivorship care plan, at median of 0.67 years (interquartile range [IQR] = 0.30-1.67 years) post-eligibility. Compared with those who received a survivorship care plan, survivors without were more likely to be older at eligibility (mean age = 11.8 [6.1] vs 11.2 [5.5] years, P = .002), non-Hispanic Black (29.5% vs 24.8%, P = .006), treated for central nervous system tumors (38.7% vs 12.4%, P < .001), or treated with surgery only (46.8% vs 1.2%, P < .001). Overall, 2.9% of survivors died at a median of 3.6 years (IQR = 2.3-5.4 years) from eligibility. In multivariable models, survivorship care plan receipt (vs nonreceipt) was associated with a lower risk of death (overall survival: adjusted hazard ratio [HR] = 0.62, 95% confidence interval [CI] = 0.39 to 0.97; P = .04; event-free survival: adjusted HR = 0.73, 95% CI = 0.54 to 0.99; P = .04).
conclusionEngagement in survivorship care, indicated by survivorship care plan receipt, was associated with superior overall and event-free survival in childhood cancer survivors, underscoring its importance in improving long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.